Skip to content

Study on the Effects of Lithium Carbonate on Bone Mass Improvement in Osteoporosis Patients with Mental Illnesses

Study on the Effects of Lithium Carbonate on Bone Mass Improvement in Osteoporosis Patients with Mental Illnesses

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111219
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-03-07
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

Oral lithium carbonate group:None
Group without using lithium carbonate (control group):None

Sponsors

Wuhan Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Psychiatric patients taking lithium carbonate for the first time; 2. Primary osteoporosis diagnosed by bone density measurement T <= -2.5 and laboratory examination in accordance with the Diagnosis and Treatment Guidelines for Primary Osteoporosis (2022); 3. Women who experience menopause or men over 60 years old; 4. The subjects voluntarily participated and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Previous history of using estrogen and anti osteoporosis drugs; 2. Using drugs that cause bone damage, such as glucocorticoids (>= 7.5mg/d prednisolone for more than 3 months); 3. Participated in other clinical trials within the past three months; 4. Women who are breastfeeding, pregnant, or preparing for pregnancy; 5. Patients who are known to be allergic to the components of the test sample or its analogues, as well as patients with oral contraindications; 6. Patients with poor treatment compliance as determined by researchers; 7. Diseases that may interfere with research results and affect bone metabolism, as well as other severe, acute, or chronic diseases; 8. Researchers believe that other situations are not suitable for inclusion or are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Bone mineral density;Bone turnover markers;

Countries

China

Contacts

Public ContactMa Jingwei

School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology

majingwei_pumc@126.com+86 159 2732 8119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026